Prudential PLC Dexcom Inc Transaction History

Prudential PLC

$19.6 Billion
Q3 2024

A detailed history of Prudential PLC transactions in Dexcom Inc stock. As of the latest transaction made, Prudential PLC holds 14,960 shares of DXCM stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,960

Previous 13,545 10.45%

Holding current value

$1.2 Million

Previous $1.54 Million 34.72%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $90,560 - $164,224	1,415 Added 10.45%	14,960 $1 Million
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $415,758 - $529,356	3,769 Added 38.55%	13,545 $1.54 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $345,972 - $424,362	-3,029 Reduced 23.65%	9,776 $1.36 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $585,575 - $963,109	-7,757 Reduced 37.72%	12,805 $1.59 Million
Q3 2023 Nov 09, 2023	BUY	$86.06 - $137.93 $583,228 - $934,751	6,777 Added 49.16%	20,562 $1.92 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $131,927 - $153,639	1,173 Added 9.3%	13,785 $1.77 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $131,872 - $155,862	-1,268 Reduced 9.14%	12,612 $1.47 Million
Q4 2022 Feb 08, 2023	BUY	$84.98 - $122.67 $654,685 - $945,049	7,704 Added 124.74%	13,880 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $51,307 - $63,288	672 Added 12.21%	6,176 $497,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $87,775 - $171,560	1,291 Added 30.64%	5,504 $410,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $169,438 - $234,490	1,801 Added 74.67%	4,213 $2.16 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $313,246 - $392,721	2,412 New	2,412 $1.3 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account